Cell of Origin and Microenvironment Contribution for NF1-Associated Dermal Neurofibromas

Cell Stem Cell

Volumn 4, Issue 5, 2009, Pages 453-463

  Le, Lu Q ^a,b   Shipman, Tracey ^a   Burns, Dennis K ^b   Parada, Luis F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

STEMCELL

Indexed keywords

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; DERMAL NEUROFIBROMA; DERMIS; DISEASE ASSOCIATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MAST CELL; MOLECULAR MECHANICS; MOUSE; NEUROFIBROMA; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; STEM CELL; WESTERN BLOTTING;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; DERMIS; MICE; MICE, TRANSGENIC; NEUROFIBROMA; NEUROFIBROMIN 1; SKIN NEOPLASMS; STEM CELLS;

EID: 65349141187     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2009.03.017     Document Type: Article

References (50)

1. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumor stem cells. Oncogene 23 (2004) 7274-7282
2. Biernaskie J.A., McKenzie I.A., Toma J.G., and Miller F.D. Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat. Protocols 1 (2006) 2803-2812
3. Biernaskie J., Sparling J.S., Liu J., Shannon C.P., Plemel J.R., Xie Y., Miller F.D., and Tetzlaff W. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J. Neurosci. 27 (2007) 9545-9559
4. Cichowski K., and Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104 (2001) 593-604
5. Cichowski K., Shih T.S., Schmitt E., Santiago S., Reilly K., McLaughlin M.E., Bronson R.T., and Jacks T. Mouse models of tumor development in neurofibromatosis type 1. Science 286 (1999) 2172-2176
6. Dugoff L., and Sujansky E. Neurofibromatosis type 1 and pregnancy. Am. J. Med. Genet. 66 (1996) 7-10
7. Fernandes K.J., McKenzie I.A., Mill P., Smith K.M., Akhavan M., Barnabe-Heider F., Biernaskie J., Junek A., Kobayashi N.R., Toma J.G., et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol. 6 (2004) 1082-1093
8. Fernandes K.J., Kobayashi N.R., Gallagher C.J., Barnabe-Heider F., Aumont A., Kaplan D.R., and Miller F.D. Analysis of the neurogenic potential of multipotent skin-derived precursors. Exp. Neurol. 201 (2006) 32-48
9. Fernandes K.J., Toma J.G., and Miller F.D. Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363 (2008) 185-198
10. Ferner R.E. Neurofibromatosis 1. Eur. J. Hum. Genet. 15 (2007) 131-138
11. Gao J.X. Cancer stem cells: the lessons from pre-cancerous stem cells. J. Cell. Mol. Med. 12 (2008) 67-96
12. Gardner D., Shoback D., and Greenspan F. Greenspan's Basic and Clinical Endocrinology (2007), McGraw-Hill Medical, New York
13. Gray G.D., Hernandez O.M., Hebel D., Root M., Pow-Sang J.M., and Wickstrom E. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice. Cancer Res. 53 (1993) 577-580
14. Hayashi S., and McMahon A.P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244 (2002) 305-318
15. Huson S.M., Harper P.S., and Compston D.A. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111 (1988) 1355-1381
16. Joseph N.M., Mosher J.T., Buchstaller J., Snider P., McKeever P.E., Lim M., Conway S.J., Parada L.F., Zhu Y., and Morrison S.J. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 13 (2008) 129-140
17. Jung-Testas I., Schumacher M., Robel P., and Baulieu E.E. Demonstration of progesterone receptors in rat Schwann cells. J. Steroid Biochem. Mol. Biol. 58 (1996) 77-82
18. Kwon C.H., Zhao D., Chen J., Alcantara S., Li Y., Burns D.K., Mason R.P., Lee E.Y., Wu H., and Parada L.F. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res. 68 (2008) 3286-3294
19. Lakkis M.M., and Tennekoon G.I. Neurofibromatosis type 1. I. General overview. J. Neurosci. Res. 62 (2000) 755-763
20. Le L.Q., and Parada L.F. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 26 (2007) 4609-4616
21. McKenzie I.A., Biernaskie J., Toma J.G., Midha R., and Miller F.D. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J. Neurosci. 26 (2006) 6651-6660
22. McLaughlin M.E., and Jacks T. Progesterone receptor expression in neurofibromas. Cancer Res. 63 (2003) 752-755
23. Miller S.J., Lavker R.M., and Sun T.T. Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim. Biophys. Acta 1756 (2005) 25-52
24. Movaghar B., Tiraihi T., and Mesbah-Namin S.A. Transdifferentiation of bone marrow stromal cells into Schwann cell phenotype using progesterone as inducer. Brain Res. 1208 (2008) 17-24
25. Nowell P.C., and Hungerford D.A. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst. 25 (1960) 85-109
26. Nussbaum J., Minami E., Laflamme M.A., Virag J.A., Ware C.B., Masino A., Muskheli V., Pabon L., Reinecke H., and Murry C.E. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21 (2007) 1345-1357
27. Overdiek A., Winner U., Mayatepek E., and Rosenbaum T. Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone. Pediatr. Res. 64 (2008) 40-43
28. Prophet, E., Mills, B., Arrington, J., and Sobin, L., eds. (1992). Laboratory Methods in Histotechnology (Washington, D.C.: American Registry of Pathology).
29. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
30. Riccardi V.M. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig. Artic. Ser. 17 (1981) 129-145
31. Roth T.M., Ramamurthy P., Muir D., Wallace M.R., Zhu Y., Chang L., and Barald K.F. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin. Dev. Dyn. 237 (2008) 513-524
32. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
33. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999) 70-71
34. Stemmer-Rachamimov A.O., Louis D.N., Nielsen G.P., Antonescu C.R., Borowsky A.D., Bronson R.T., Burns D.K., Cervera P., McLaughlin M.E., Reifenberger G., et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res. 64 (2004) 3718-3724
35. Stenback F., Peto R., and Shubik P. Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells. Br. J. Cancer 44 (1981) 1-14
36. Stindl R. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells. Med. Hypotheses 71 (2008) 126-140
37. Szudek J., Birch P., Riccardi V.M., Evans D.G., and Friedman J.M. Associations of clinical features in neurofibromatosis 1 (NF1). Genet. Epidemiol. 19 (2000) 429-439
38. Toma J.G., Akhavan M., Fernandes K.J., Barnabe-Heider F., Sadikot A., Kaplan D.R., and Miller F.D. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3 (2001) 778-784
39. Toma J.G., McKenzie I.A., Bagli D., and Miller F.D. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23 (2005) 727-737
40. Trovo-Marqui A.B., and Tajara E.H. Neurofibromin: a general outlook. Clin. Genet. 70 (2006) 1-13
41. Vogel K.S., Klesse L.J., Velasco-Miguel S., Meyers K., Rushing E.J., and Parada L.F. Mouse tumor model for neurofibromatosis type 1. Science 286 (1999) 2176-2179
42. Ward B.A., and Gutmann D.H. Neurofibromatosis 1: from lab bench to clinic. Pediatr. Neurol. 32 (2005) 221-228
43. Wong S., and Witte O.N. The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 22 (2004) 247-306
44. Wu J., Williams J.P., Rizvi T.A., Kordich J.J., Witte D., Meijer D., Stemmer-Rachamimov A.O., Cancelas J.A., and Ratner N. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13 (2008) 105-116
45. Yang F.C., Ingram D.A., Chen S., Hingtgen C.M., Ratner N., Monk K.R., Clegg T., White H., Mead L., Wenning M.J., et al. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J. Clin. Invest. 112 (2003) 1851-1861
46. Yang F.C., Chen S., Clegg T., Li X., Morgan T., Estwick S.A., Yuan J., Khalaf W., Burgin S., Travers J., et al. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum. Mol. Genet. 15 (2006) 2421-2437
47. Yang F.C., Ingram D.A., Chen S., Zhu Y., Yuan J., Li X., Yang X., Knowles S., Horn W., Li Y., et al. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow. Cell 135 (2008) 437-448
48. Zheng H., Chang L., Patel N., Yang J., Lowe L., Burns D.K., and Zhu Y. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Cancer Cell 13 (2008) 117-128
49. Zhu Y., and Parada L.F. Neurofibromin, a tumor suppressor in the nervous system. Exp. Cell Res. 264 (2001) 19-28
50. Zhu Y., Ghosh P., Charnay P., Burns D.K., and Parada L.F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296 (2002) 920-922